Alcohol and Gender Effects on Stress Circuit Function
NCT00226694 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2014-01-07
Summary
The purpose of this study is to look at the stress hormone response to medication-induced stress and a placebo (an inactive compound) in non-drinking, recovering male and female alcoholics, with a specific emphasis on the differences between men and women in the two recovering alcoholic groups.
Conditions
- Alcoholism
- Stress
- Alcohol Dependence
Interventions
- DRUG
-
Citalopram
Subjects receive provocative tests with citalopram, dexamethasone/corticotropin-releasing hormone and placebo on 3 separate, counterbalanced occasions at monthly intervals.
- OTHER
-
Placebo
Subjects receive provocative tests with citalopram, dexamethasone/corticotropin-releasing hormone and placebo on 3 separate, counterbalanced occasions at monthly intervals.
Sponsors & Collaborators
-
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
collaborator NIH -
University of Cincinnati
lead OTHER
Principal Investigators
-
Robert M. Anthenelli, MD · US Department of Veterans Affairs
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-09-30
- Primary Completion
- 2011-08-31
- Completion
- 2012-08-31
Countries
- United States
Study Locations
More Related Trials
-
Oxytocin and Stress Response in Alcohol Use Disorder
NCT03610633 ·Status: COMPLETED ·Phase: PHASE2
-
Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes
NCT03056872 ·Status: COMPLETED
-
Impulsivity Domains and Subjective Response
NCT05929677 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.
NCT00230425 ·Status: COMPLETED
-
Oxytocin Treatment for Alcohol Use Disorders
NCT03636555 ·Status: WITHDRAWN ·Phase: PHASE2
-
Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
NCT05223829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics
NCT01657760 ·Status: COMPLETED ·Phase: PHASE1
-
Cerebellar Involvement in Alcohol Use Disorder (AUD)
NCT05732207 ·Status: RECRUITING ·Phase: NA
-
Approach-Avoidance and Alcohol Challenge Study in PTSD
NCT06002633 ·Status: RECRUITING ·Phase: NA
-
Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study
NCT02181569 ·Status: COMPLETED
-
The Role of the Glutamatergic System in the Extinction of Conditioned Reinforcement Processes
NCT00926900 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effects of THC on Alcohol Consumption and Neural Correlates of Reward
NCT06446479 ·Status: RECRUITING ·Phase: PHASE2
-
INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers
NCT02989662 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder
NCT03535129 ·Status: COMPLETED ·Phase: NA
-
The Alcohol-Pain Connection: Mechanisms and Genetic/Psychological Correlates
NCT03311594 ·Status: COMPLETED ·Phase: PHASE1
-
Oxytocin to Enhance Integrated Treatment for AUD and PTSD
NCT04523922 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Effects of Oxytocin on Startle Hyperreactivity in Patients With AUD and PTSD
NCT02469259 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Metabolism of Chlordiazepoxide in the Treatment of Alcohol Withdrawal Symptoms
NCT05563350 ·Status: COMPLETED
-
Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder
NCT05656534 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Neural Correlates of Cannabis Use
NCT03104257 ·Status: COMPLETED
-
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT04931095 ·Status: COMPLETED ·Phase: PHASE1
-
Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder
NCT05421065 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Intranasal Oxytocin and Social Cognition, Implicit Preferences and Craving in Alcohol Drinkers
NCT01829516 ·Status: COMPLETED ·Phase: PHASE4
-
Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder
NCT02407340 ·Status: COMPLETED ·Phase: PHASE1
-
Neurobehavioral Profiles of Adaptive Stress Responses in Individuals With Alcohol Use Disorder
NCT06105853 ·Status: RECRUITING ·Phase: NA